Exploratory Study on POL6326 in Stem Cell Mobilization
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
- Status
- COMPLETED
- Phase
- PHASE4
Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure
- Status
- COMPLETED
- Phase
- PHASE2
Connect® MM- The Multiple Myeloma Disease Registry
- Status
- TERMINATED
- Phase
- N/A
Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
- Status
- COMPLETED
- Phase
- N/A
Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2